Abstract | PURPOSE: MATERIALS AND METHODS: BMD patients with CNV treated using PDT and/or IV were included in the study. All patients underwent a complete ophthalmological examination, OCT and 3 × 3 mm OCT-A. The OCT-A images were analyzed using an open-source software (ImageJ) to assess the CNV membrane area (CNV-MA), the CNV vessel area (CNV-VA), and vessel density (VD) at the follow-ups (3 months after PDT and 1 month after IV). RESULTS: Five eyes of four patients with CNV were included. All eyes received PDT as first-line therapy; 4 eyes underwent more than 1 treatment session: three eyes received 1 IV, whereas one eye had one further PDT. After PDT, the CNV-MA, CNV-VA, and VD quantitative parameters were obtained for four out of five eyes: in three eyes of two patients CNV-MA, CNV-VA, and VD first decreased and then gradually increased during follow-up, whereas in one eye of one patient CNV-MA, CNV-VA, and VD slightly increased. After IV the CNV-MA, CNV-VA, and VD had significantly decreased at the 1-month follow-up in three eyes of three patients. CONCLUSION: OCT-A is an important tool for the diagnosis of both naïve and fibrotic CNV in BMD patients; it is a non-invasive method for the qualitative and quantitative analysis of neovascular lesions during follow-up. Our results have shown a cyclic remodeling of treated CNV in BMD patients using both PDT and IV.
|
Authors | Vittoria Murro, Dario Pasquale Mucciolo, Dario Giorgio, Andrea Sodi, Ilaria Passerini, Francesca Cipollini, Gianni Virgili, Fabrizio Giansanti |
Journal | Ophthalmic genetics
(Ophthalmic Genet)
Vol. 41
Issue 5
Pg. 440-447
(10 2020)
ISSN: 1744-5094 [Electronic] England |
PMID | 32643503
(Publication Type: Case Reports, Journal Article)
|
Topics |
- Adolescent
- Child
- Choroidal Neovascularization
(diagnostic imaging, drug therapy, pathology)
- Female
- Fluorescein Angiography
(methods)
- Humans
- Male
- Photochemotherapy
(methods)
- Retrospective Studies
- Tomography, Optical Coherence
(methods)
- Visual Acuity
- Vitelliform Macular Dystrophy
(drug therapy, physiopathology)
|